Luminex and ACMGF announce annual grant for genetic research January 29 Award Applications due, 2010 The American University of Medical Genetics Foundation/ACMGF ; b. Agreement of applicant’s institution; c www.medicine-rx.com . Project not funded by another entity outside of the applicant’s institution; d. Project to be substantially performed in the United States or Canada; and e. Task is executable in one year. SOURCE American University of Medical Genetics.
I am excited to see ACT’s new radiometry technology provide two new features for the very first time in left-sided ablation procedures. The business’s technology offers real-time safe temperatures control during ablations and in the near term guarantees automated titration of RF capacity to create consistent, wide and deep lesions.’.. ACT’s TEMPASURE cardiac ablation catheter receives CE Mark Advanced Cardiac Therapeutics, Inc. The TEMPASURE system may be the world’s initial RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology. The system’s novel passive sensing microwave radiometry technology allows the electrophysiologist to gauge the temp of cardiac tissue during the ablation procedure, providing real-time information that enables proper energy delivery and lesion control.